Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Somewhat off topic but related to Generex/Olaregen

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36568
(Total Views: 883)
Posted On: 06/05/2020 8:49:56 PM
Posted By: docj
Somewhat off topic but related to Generex/Olaregen. The company who owned Excellagen, Taxus Cardium went dark like Generex. Hasn't kept up their filings. They changed their name to Gene Biotherapeutics a while back but kept the CRXM stock symbol. Somewhere in there they sold most of the Excellagen rights to Olaregen. I believe they are still owed money and royalty payments from Excellagen sales. They just announced an investment by a guy who owns a pharma company based in Jersey. I have kept in touch with CRXM's CEO, Chris Reinhard. He plans to bring the companies financials up to date and is planning on continuing trials on their genetic heart technology platform "Generx"LOL, that is too funny). Unfortunately, the investment included the potential to dilute the common shares so I don't know what will happen to the PPS if they have to sell shares to raise money to fund the new trial. I have owned shares for long time so I am thrilled something is happening although I consider my investment a complete loss until proven otherwise. The trading volume is pathetic and has been down on the news so the dilution may be a concern. Anyway, the pharma company investor does a couple hundred million in revenue per year so I am told by an individual shareholder who owns 14% (confirmed by SEC filing) of the common. Between his shares, two of his friends and myself we control 22% plus of the common for now. Insiders have about 12% if yahoo is accurate. Anyway, it is a slow Friday night so I thought I would share given the olaregen/excellagen connection. I am not recommending anyone buy shares.


(1)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us